Bridges Consumer Healthcare Announces Acquisition KT Tape

by Brian Mullin on January 23, 2025

bridges_kt_Tape_header

Bridges Consumer Healthcare Announces Acquisition of Category-Leading Consumer Health Brand KT Tape

Bridges Consumer Healthcare (“Bridges” or the “Company”), a consumer healthcare platform made up of nine over-the-counter (“OTC”) and personal care brands, announced the acquisition of KT Tape (“KT”), the leading kinesiology tape brand designed to provide drug-free pain relief and support for muscles, tendons, and ligaments. The strategic move diversifies and strengthens Bridges’ portfolio of specialty OTC brands, increasing the Company’s scale and positioning Bridges for accelerated organic growth and further add-on opportunities. Terms of the transaction were not disclosed.

kt_tape_inuse

Founded in 2008, KT Tape has pioneered drug-free, innovative solutions to prevent and relieve pain and promote recovery. The company partnered with Palladin Consumer Retail Partners (“Palladin”) in 2014 and has earned high customer advocacy with products that appeal to all consumers, from professional athletes to those seeking effective relief from everyday pain and soreness. KT is a category leader used by notable athletic organizations, including the U.S. Olympic and Paralympic Teams. Adding KT to Bridges represents the next growth phase for the brand, with further investment in demand generation, product innovation, and omnichannel distribution as part of the Bridges platform. KT is also the fourth acquisition completed since the inception of Bridges and opens the door for additional opportunities for accretive M&A.

bridges_kt_Tape_2

“We are excited to join forces with KT Tape to advance our shared goal of delivering innovative over-the-counter healthcare solutions to improve our customers’ everyday health and quality of life,” said John Speranza, CEO at Bridges Consumer Healthcare. “KT’s innovative solutions enhance Bridges’ already-strong position in pain relief, alongside our current brands in the external pain category, ThermaCare and Absorbine Jr. As we begin executing on our vision for growth, we look forward to exploring partnerships with similar brands that can help us scale further.”

kt_tape_inuse_2

“Today’s announcement marks an exciting new chapter for KT, positioning us to reach more customers and continue to drive meaningful innovation through the added scale of the Bridges platform,” said Jessica Klodnicki, CEO at KT Tape. “We have been impressed by Bridges’ leadership and depth of expertise across several consumer health verticals, as well as the Company’s steadfast focus on its customers. We are thrilled to have found another collaborative strategic partner that shares a similar vision for the future of our business.”

bridges_brands_1

Bridges was founded in 2020 by a team of industry executives and Charlesbank Capital Partners to build a market-leading consumer healthcare platform. Since its formation, Bridges has executed this mission, acquiring nine brands focused on pain relief, women’s health, and supplements and accelerating double-digit growth through strategic marketing, innovation, and a diverse range of sales channels, including e-commerce and B2B partnerships.

“Since its formation, Bridges has demonstrated a strong track record of growth, scaling both organically and through M&A, and we are thrilled to welcome another marquee brand like KT to the Bridges family,” said Jesse Ge, Principal at Charlesbank. “This marks an exciting milestone for the Bridges team, as they continue to build a leading consumer healthcare company.”

Mark Schwartz, CEO of Palladin, added, “It has been a pleasure working with the founders of KT, Jessica and the entire leadership team to build a leading consumer product company providing health and wellness solutions for athletes at all levels. We’re confident that Bridges will be a good platform for KT’s next stage of growth.”

Weil, Gotshal, and Manges served as legal counsel to Bridges and Charlesbank. Palladin and KT were represented by Houlihan Lokey and advised by Latham & Watkins, RSM US, and Andersen.

 

{ 0 comments… add one now }

Leave a Comment

Previous post:

Next post: